ReviewDiabetes, obesity & metabolism2021

The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update.

Michael A Nauck et al.PubMed ↗Publisher ↗

No numbers read from the abstract.